ESR1 and breast cancer: This requirement for p38 MAPK activation appears to be conserved between ER+ and HER2+ breast cancer cells; we previously showed that p38 activation is required for apoptosis of lapatinib-resistant HER2+ breast cancer cells in which PTK6 expression was downregulated.25